Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

Transurethral surgery in the treatment of invasive bladder cancer (T1 and T2).

Publikation: Bidrag til tidsskriftTidsskriftartikel

  • H Wolf
  • H G Iversen
  • P Rosenkilde
  • T Schrøder
Vis graf over relationer
Ninety-nine primary transitional cell bladder tumours of categories T1 or T2 were treated by transurethral resection. 25% of these patients experienced a true recurrence indicating that surgery failed to control the tumour locally. These patients had a 5-year survival of 20%. We suspect that many of them did not have local disease when treated. Twenty-five % of the total patient population did not within five years get a new tumour. They were cured by the first transurethral resection. 30% of the patients experienced new non-invasive tumour growth that could be managed by repeated resections. These two groups of patients did extremely well, since the 5-year survival was equivalent to the 5-year survival of an age and sex matched control population. Thus, more than 50% of the patients benefitted from transurethral surgery. Less than 20% experienced a new invasive tumour growth. They are patients at risk of getting a progressive bladder cancer disease. 5-year survival of these patients was about 50%. We conclude that transitional cell bladder tumours of category T1 and some of category T2 are well treated by transurethral resection.
Bidragets oversatte titelTransurethral surgery in the treatment of invasive bladder cancer (T1 and T2).
OriginalsprogEngelsk
TidsskriftScandinavian Journal of Urology and Nephrology
Vol/bind104
Sider (fra-til)127-132
Antal sider6
ISSN0036-5599
StatusUdgivet - 1987

ID: 32531740